Company news

Geron Corporation news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial

April 25, 2023

Geron to Present at Upcoming Investor Conferences in April

April 11, 2023

Geron Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Milestones

March 15, 2023

Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023

March 8, 2023

Geron to Present at the B. Riley Securities 3rd Annual Virtual Oncology Conference

January 11, 2023

Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S.

January 10, 2023

Geron Corporation Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants Plus Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $227.8 Million

January 9, 2023

Geron Corporation Announces Pricing of $198 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants

January 4, 2023

Geron Corporation Announces Proposed Public Offering of Common Stock

January 3, 2023

Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS

January 3, 2023

Geron Announces Conference Call for Top-Line Results from IMerge Phase 3

January 2, 2023

Geron Reports Oral Presentation at ASH Annual Meeting Highlighting Continuous Long-Term Transfusion Independence with Imetelstat Treatment in Lower Risk MDS Patients

December 11, 2022

Geron to Participate in Stifel 2022 Healthcare Conference

November 6, 2022

Geron Corporation Reports Third Quarter 2022 Financial Results and Upcoming Expected Milestones

November 2, 2022

Geron Announces Presentations at Upcoming ASH Annual Meeting Including Long-term Phase 2 Data Showing Continuous Durable Transfusion Independence in Patients with Lower Risk MDS

November 2, 2022

Geron to Announce Third Quarter 2022 Financial Results on November 3, 2022

October 26, 2022

Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors

September 7, 2022

Geron to Present at Upcoming Investor Conferences

August 31, 2022

Geron Announces First Patient Dosed in IMproveMF Phase 1 Combination Study in Frontline Myelofibrosis

August 21, 2022

Geron Corporation Reports Second Quarter 2022 Financial Results

August 10, 2022

Geron to Announce Second Quarter 2022 Financial Results on August 11, 2022

August 3, 2022

Geron to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference

August 2, 2022

Geron Corporation Announces Expansion of Existing Loan Facility

June 29, 2022

Geron Corporation Announces Appointment of Faye Feller, M.D. to Chief Medical Officer and Transition of Aleksandra Rizo, M.D., Ph.D. to Senior Advisor Role

June 14, 2022

Geron to Present at the H.C. Wainwright Global Investment Conference

May 16, 2022

Geron Corporation Reports First Quarter 2022 Financial Results

May 8, 2022

Geron to Announce First Quarter 2022 Financial Results on May 9, 2022

May 1, 2022

Geron to Present at the 21st Annual Needham Virtual Healthcare Conference

April 5, 2022

Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants

March 31, 2022

Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants

March 29, 2022

Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants

March 28, 2022

Geron Corporation Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Milestones

March 9, 2022

Geron to Announce Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022

March 2, 2022

Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference

January 20, 2022

Geron to Present at the H.C. Wainwright BioConnect Conference

January 3, 2022

Geron Reports Presentations at American Society of Hematology Annual Meeting

December 13, 2021

Geron Announces Appointment of Chief Business Officer

December 1, 2021

Geron to Present at the Stifel 2021 Virtual Healthcare Conference

November 11, 2021

Geron Presents Investor Event Highlights

November 8, 2021

Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting

November 3, 2021

Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat

October 24, 2021

Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes

October 17, 2021

Geron to Host a Virtual Investor Event in November

October 14, 2021

Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology

October 10, 2021

Geron Announces September Investor Conference Presentation Webcasts

August 31, 2021

Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023

August 15, 2021

Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021

August 4, 2021

Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology

June 16, 2021

Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress

June 13, 2021

Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress

May 11, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 32 decks. Every deck is listed under its year.